FIELD: complex iron compounds.
SUBSTANCE: method for producing complex iron compounds. The proposed method includes the steps of: (i) providing an iron preparation containing iron in a form selected from water-soluble iron salt, iron hydroxide or iron oxide-hydroxide, where the amount of arsenic in the iron preparation does not exceed 4.5 mcg per g of iron and the amount of lead in the iron preparation does not exceed 1.5 mcg per g of iron; and (ii) contacting the iron preparation with a carbohydrate ligand in the presence of water to produce an iron-carbohydrate complex compound.
EFFECT: providing a method for producing iron products that are safe for administration to humans and farm animals, as well as for people who consume food that is an animal product.
11 cl, 1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
COMPLEX COMPOUNDS OF IRON WITH CARBOHYDRATES | 2008 |
|
RU2423122C2 |
PREPARATION CONTAINING COMPLEX IRON (III) COMPOUNDS AND ACTIVE REDOX SUBSTANCE | 2006 |
|
RU2394597C2 |
METHOD OF PURIFYING WATER FROM ARSENIC COMPOUNDS | 2019 |
|
RU2725315C1 |
HYBRID SORBENT | 2017 |
|
RU2665439C1 |
IRON-CONTAINING COMPOSITIONS FOR PARENTERAL FEEDING | 2006 |
|
RU2427364C2 |
COMPOUNDS CONTAINING TRIAZINONES AND IRON | 2008 |
|
RU2506081C9 |
METHOD OF REMOVING ARSENIC FROM WASTE WATERS AND AQUEOUS SOLUTIONS OF ALKALI METALS | 1993 |
|
RU2100288C1 |
METHOD FOR REMOVING ARSENIC COMPOUNDS FROM DRINKING WATER | 2015 |
|
RU2598935C1 |
APPLICATION OF COMPLEX IRON (III) COMPOUNDS FOR PREPARING ORAL DRUG FOR IRON DEFICIENCIES IN PATIENTS SUFFERING CHRONIC INFLAMMATORY INTESTINAL DISEASES | 2006 |
|
RU2411037C2 |
APPLICATION OF COMPLEX BONDS OF IRON (III) | 2006 |
|
RU2359680C2 |
Authors
Dates
2024-01-30—Published
2018-09-10—Filed